Latest News

Advocacy

HOPA and CMRignite Launch "Time to Talk Diversity in Clinical Trials" Campaign

HOPA and CMRignite have collaborated on "Time to Talk Diversity in Clinical Trials," a campaign to address the critical need for increased diversity in cancer clinical research and ensure that all patient populations are adequately represented.

Advocacy

Pharmacists & Patients Lend Their Voices to Virtual Hill Day

HOPA members, patients, and caregivers participated in a total of 80 meetings with representatives from 31 states.

Advocacy

HOPA Supports Pharmacists, Hopes for Workplace Conditions that Optimize Patient Care

The pharmacy profession is experiencing unprecedented rates of burnout and good-faith and timely talks are key to swift and satisfactory workforce negotiations.

Advocacy

Oncology Experts Join Together to Provide Best Possible Care for Adolescents and Young Adults with Cancer

The Hematology/Oncology Pharmacy Association (HOPA) has partnered with Stupid Cancer, the leader in young adult cancer advocacy, research, and support, to develop tools for healthcare providers who serve the adolescent and young adult (AYA) patient commun

Advocacy

Oncology pharmacy practice in the United States: Results of a comprehensive, nationwide survey

The survey was developed by the HOPA Practice Outcomes and Professional Benchmarking Committee (POPBC) and distributed between March 2021 and January 2022

Pharmacist talking to a customer
Advocacy

The Value of Oncology Pharmacists Op-Ed

With Drug Shortages and Errors on the Rise, Oncology Pharmacists are Vital to Navigate Treatment in the Era of a Pandemic

Pharmacist talking to a customer
Advocacy

The Role of the Pharmacist after Dobbs v. Jackson Women’s Health Organization Ruling

The Hematology/Oncology Pharmacy Association (HOPA) is committed to optimizing cancer care for all individuals. The recent U.S. Supreme Court decision, which overturned Roe v. Wade, imposes a significant barrier to the oncology community’s ability to ens

Advocacy

HOPA Issues Drug Shortages Brief

Drug shortages present serious challenges for HOPA members in their efforts to provide optimal care to individuals affected by cancer. Shortages of drugs that are essential for the treatment and care of individuals with cancer result in c

Advocacy

HOPA Calls for Appointment of Pharmacy Professionals to Federal COVID-19 Health Equity Task Force

HOPA has joined with 13 other pharmacy organizations to call on the White House to ensure pharmacy professionals are represented in the administration’s newly appointed COVID-19 Health Equity Task Force.

Person recieiving vaccine
Advocacy

5 Guiding Principles of COVID-19 Vaccine Distribution and Administration

HOPA joins the scientific community and public with enthusiasm on the recent historic Emergency Use Authorization approvals for the Pfizer-BioNTech ​and Moderna COVID-19 vaccine​s